OTC Markets OTCPK - Delayed Quote USD

Raia Drogasil S.A. (RADLY)

2.6000
0.0000
(0.00%)
At close: May 21 at 4:00:00 PM EDT
Loading Chart for RADLY
  • Previous Close 0.0000
  • Open 2.8500
  • Bid 2.4200 x 40000
  • Ask 2.8400 x 45900
  • Day's Range 2.7500 - 2.8500
  • 52 Week Range 2.4200 - 14.0000
  • Volume 2,470
  • Avg. Volume 2,158
  • Market Cap (intraday) 4.504B
  • Beta (5Y Monthly) 0.24
  • PE Ratio (TTM) 20.00
  • EPS (TTM) 0.1300
  • Earnings Date Aug 5, 2025
  • Forward Dividend & Yield 0.05 (2.06%)
  • Ex-Dividend Date May 1, 2025
  • 1y Target Est 6.60

Raia Drogasil S.A. engages in the retail sale of medicines, perfumery, personal care and beauty products, cosmetics, dermocosmetics, and specialty medicines in Brazil. It sells its products through stores, telesales, and call centers in the states of São Paulo, Tocantins, and Pernambuco. The company was founded in 1905 and is headquartered in São Paulo, Brazil.

rdsaude.com.br

66,275

Full Time Employees

December 31

Fiscal Year Ends

Recent News: RADLY

View More

Performance Overview: RADLY

Trailing total returns as of 5/21/2025, which may include dividends or other distributions. Benchmark is IBOVESPA (^BVSP) .

YTD Return

RADLY
23.08%
IBOVESPA (^BVSP)
14.63%

1-Year Return

RADLY
46.47%
IBOVESPA (^BVSP)
8.22%

3-Year Return

RADLY
28.96%
IBOVESPA (^BVSP)
27.09%

5-Year Return

RADLY
24.77%
IBOVESPA (^BVSP)
66.07%

Compare To: RADLY

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: RADLY

View More

Valuation Measures

Annual
As of 5/21/2025
  • Market Cap

    --

  • Enterprise Value

    --

  • Trailing P/E

    20.68

  • Forward P/E

    24.15

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    3.88

  • Enterprise Value/Revenue

    0.82

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    2.95%

  • Return on Assets (ttm)

    6.76%

  • Return on Equity (ttm)

    18.68%

  • Revenue (ttm)

    39.81B

  • Net Income Avi to Common (ttm)

    1.17B

  • Diluted EPS (ttm)

    0.1300

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    470.18M

  • Total Debt/Equity (mrq)

    118.73%

  • Levered Free Cash Flow (ttm)

    1.36B

Research Analysis: RADLY

View More

Company Insights: RADLY

Research Reports: RADLY

View More

People Also Watch